相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression-TRANSFORM-3
Rachel Ochs-Ross et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2020)
Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials
Katrina Witt et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2020)
Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study
Fernanda S. Correia-Melo et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
A historical review of antidepressant effects of ketamine and its enantiomers
Yan Wei et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
Pharmacokinetics, absolute bioavailability and tolerability of ketamine after intranasal administration to dexmedetomidine sedated dogs
Lise Vlerick et al.
PLOS ONE (2020)
Is (S)-norketamine an alternative antidepressant for esketamine?
Kenji Hashimoto et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2019)
Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebo-controlled, proof-of-concept study
Yoav Domany et al.
BRITISH JOURNAL OF PSYCHIATRY (2019)
Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial
Dawn F. Ionescu et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
Vanina Popova et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
A Word to the Wise About Intranasal Esketamine
Alan F. Schatzberg
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
Maggie Fedgchin et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2019)
New WHO prevalence estimates of mental disorders in conflict settings: a systematic review and meta-analysis
Fiona Charlson et al.
LANCET (2019)
Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
Kenji Hashimoto
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2019)
Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism
Nolan R. Williams et al.
MOLECULAR PSYCHIATRY (2019)
Ketamine and depression: a narrative review
Alexandrine Corriger et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
Sanne Y. Smith-Apeldoorn et al.
BMC PSYCHIATRY (2019)
Lack of Opioid System in the Antidepressant Actions of Ketamine
Kai Zhang et al.
BIOLOGICAL PSYCHIATRY (2019)
An update on ketamine and its two enantiomers as rapid-acting antidepressants
Kai Zhang et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2019)
Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
Bashkim Kadriu et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2019)
Reducing the global burden of depression: a Lancet-World Psychiatric Association Commission
Helen Herrman et al.
LANCET (2019)
Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial
Jennifer L. Phillips et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial
Michael F. Grunebaum et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
Samuel T. Wilkinson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
Carla M. Canuso et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration
Jennifer W. Evans et al.
BIOLOGICAL PSYCHIATRY (2018)
Esketamine counters opioid-induced respiratory depression
K. Jonkman et al.
BRITISH JOURNAL OF ANAESTHESIA (2018)
Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial
Somaye Arabzadeh et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial
Veronica Galvez et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Mechanisms of ketamine action as an antidepressant
P. Zanos et al.
MOLECULAR PSYCHIATRY (2018)
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Panos Zanos et al.
PHARMACOLOGICAL REVIEWS (2018)
Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression A Randomized Clinical Trial
Ella J. Daly et al.
JAMA PSYCHIATRY (2018)
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
Nolan R. Williams et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Comparative study of esketamine and racemic ketamine in treatment-resistant depression Protocol for a non-inferiority clinical trial
Fernanda S. Correia-Melo et al.
MEDICINE (2018)
Administration of ketamine for unipolar and bipolar depression
Christoph Kraus et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2017)
What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities
S. E. Strasburger et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2017)
Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism
Lily R. Aleksandrova et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2017)
Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression
Tung-Ping Su et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Efficacy and safety of ketamine in bipolar depression: A systematic review
Susana Alberich et al.
REVISTA DE PSIQUIATRIA Y SALUD MENTAL (2017)
Pilot Randomized Controlled Trial of Titrated Subcutaneous Ketamine in Older Patients with Treatment-Resistant Depression
Duncan George et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2017)
Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam-controlled randomized clinical trial
Michael F. Grunebaum et al.
BIPOLAR DISORDERS (2017)
Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression
Marc S. Lener et al.
DRUGS (2017)
Use of repeated intravenous ketamine therapy in treatment-resistant bipolar depression with suicidal behaviour: a case report from Spain
Alvaro Lopez-Diaz et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2017)
Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis
Ying Xu et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study
Y. -D. Hu et al.
PSYCHOLOGICAL MEDICINE (2016)
Ketamine use in current clinical practice
Mei Gao et al.
ACTA PHARMACOLOGICA SINICA (2016)
Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression
C. K. Loo et al.
ACTA PSYCHIATRICA SCANDINAVICA (2016)
A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
Jaskaran B. Singh et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
Jaskaran B. Singh et al.
BIOLOGICAL PSYCHIATRY (2016)
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments
Sidney H. Kennedy et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2016)
KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE
William V. Bobo et al.
DEPRESSION AND ANXIETY (2016)
Ketamine: 50 Years of Modulating the Mind
Linda Li et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2016)
The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study
Cheng-Ta Li et al.
HUMAN BRAIN MAPPING (2016)
Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial
Morteza Jafarinia et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study
Dawn F. Ionescu et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
Ketamine: NMDA Receptors and Beyond
Charles F. Zorumski et al.
JOURNAL OF NEUROSCIENCE (2016)
A Double-Blinded, Randomized, Placebo-Controlled Sub-Dissociative Dose Ketamine Pilot Study in the Treatment of Acute Depression and Suicidality in a Military Emergency Department Setting
John Burger et al.
MILITARY MEDICINE (2016)
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Panos Zanos et al.
NATURE (2016)
Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies
Yu Han et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2016)
Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
D. Jeffrey Newport et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics
Chadi G. Abdallah et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Ketamine as a novel treatment for major depressive disorder and bipolar depression: a systematic review and quantitative meta-analysis
Ellen E. Lee et al.
GENERAL HOSPITAL PSYCHIATRY (2015)
A systematic review and meta-analysis of randomized controlled trials of adjunctive ketamine in electroconvulsive therapy: Efficacy and tolerability
Alexander McGirr et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2015)
Ketamine as a Potential Treatment for Suicidal Ideation: A Systematic Review of the Literature
Lael Reinstatler et al.
DRUGS IN R&D (2015)
A single infusion of ketamine improves depression scores in patients with anxious bipolar depression
Dawn F. Ionescu et al.
BIPOLAR DISORDERS (2015)
Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults
Tayla L. McCloud et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
Ketamine and other glutamate receptor modulators for depression in adults
Caroline Caddy et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
Kyle A. B. Lapidus et al.
BIOLOGICAL PSYCHIATRY (2014)
Effect of Baseline Anxious Depression on Initial and Sustained Antidepressant Response to Ketamine
Dawn F. Ionescu et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder
Mehdi Ghasemi et al.
PSYCHIATRY RESEARCH (2014)
Ketamine administration in depressive disorders: a systematic review and meta-analysis
Guillaume Fond et al.
PSYCHOPHARMACOLOGY (2014)
Ketamine - More mechanisms of action than just NMDA blockade
Jamie Sleigh et al.
TRENDS IN ANAESTHESIA AND CRITICAL CARE (2014)
Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
James W. Murrough et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
James W. Murrough et al.
BIOLOGICAL PSYCHIATRY (2013)
Imputation of response rates from means and standard deviations in schizophrenia
Myrto T. Samara et al.
SCHIZOPHRENIA RESEARCH (2013)
Ketamine for Depression: Where Do We Go from Here?
Marije Aan Het Rot et al.
BIOLOGICAL PSYCHIATRY (2012)
Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
Carlos A. Zarate et al.
BIOLOGICAL PSYCHIATRY (2012)
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Toxicity of Subcutaneous Ketamine in the Management of Cancer Pain
Janet Hardy et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled Study
Lobna Ibrahim et al.
NEUROPSYCHOPHARMACOLOGY (2012)
A Case of Sustained Remission Following an Acute Course of Ketamine in Treatment-Resistant Depression
James W. Murrough et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
Nancy Diazgranados et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial
Sanjay J. Mathew et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati et al.
PLOS MEDICINE (2009)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Comparison of two methods to detect publication bias in meta-analysis
JL Peters et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression
CA Zarate et al.
BIOLOGICAL PSYCHIATRY (2005)
Small-dose ketamine improves the postoperative state of depressed patients
A Kudoh et al.
ANESTHESIA AND ANALGESIA (2002)
The involvement of the μ-opioid receptor in ketamine-induced respiratory depression and antinociception
E Sarton et al.
ANESTHESIA AND ANALGESIA (2001)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
分享论文
